Skip to content
10-K

Annual Report

Raphael Pharmaceutical Inc. RAPH

0001213900-25-026214

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 19.63M sh
Short Term Debt FY 2024 · Dec 31, 2024 150K
Short Term Debt FY 2024 · Dec 31, 2024 $41K
Cash And Equivalents FY 2024 · Dec 31, 2024 $19K
Cash And Equivalents FY 2024 · Dec 31, 2023 $230K
Shares Diluted FY 2024 · Dec 31, 2023 16.72M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.2M
Current Liabilities restated FY 2024 · Dec 31, 2023 $132K
Current Assets restated FY 2024 · Dec 31, 2023 $237K
Total Assets restated FY 2024 · Dec 31, 2023 $239K
Eps Diluted restated FY 2024 · Dec 31, 2023 $0.08
Eps Basic restated FY 2024 · Dec 31, 2023 $0.08
Sga Expense restated FY 2024 · Dec 31, 2023 $763K
Rd Expense FY 2024 · Dec 31, 2023 $569K
Net Income restated FY 2024 · Dec 31, 2023 −$1.34M
Operating Income restated FY 2024 · Dec 31, 2023 −$1.33M
Stock Issued FY 2024 · Dec 31, 2022 160K sh
Stock Issued FY 2024 · Dec 30, 2022 6K sh